Jun. 25 at 10:07 PM
$BRKR $ICLR $MEDP
NIH directs staff not to end any extra research projects for now, NY Times says
A senior official the National Institutes of Health has told agency staff not to cancel any more research projects for the time being in the wake of two court rulings taking umbrage with the cancellation of medical research grants by the Trump administration, the New York Times' Benjamin Mueller reports, citing an internal memo.
The directive marks a retreat by the agency, as it has slashed funding for medical research since Trump's return to office by terminating hundreds of awards, the author notes. Shares of Illumina (ILMN), Thermo Fisher (TMO), Avantor (AVTR), and Bruker (BRKR) moved higher following the news while Icon (ICLR) and Medpace (MEDP) were still in the red but curtailed some earlier losses.